← All organizations

Tolmar Inc.

For profitWebsite ↗

Also known as: TOLMAR | Tolmar Inc. | TOLMAR THERAP

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

First marketed drug

Last known activity

May 10, 2024

Timeline

1990s

Sep 3, 1998
doxycycline— NDA Secondary Org

2000s

Aug 5, 2005
clobetasol— Marketing Organization
Jun 1, 2006
Tolmar Inc.— Founded
Jul 1, 2009
Zila Biotechnology, Inc.— Acquired
Oct 1, 2009
QLT Photo Therapeutics— Acquired

Drugs by trial phase (9 distinct, 6 trials)

Phase 4 (1 own, 0 via acquisition)

testosterone

Phase 3 (5 own, 1 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 3 total across the full acquisition tree)

Recent trials (5)

NCT06385509Lead sponsorPhase 4May 10, 2024
NCT05645536Lead sponsorPhase 3Dec 31, 2022
NCT04906395Lead sponsorPhase 3Jul 1, 2021
NCT03122353Lead sponsorPhase 1Apr 11, 2017
NCT02452931Lead sponsorPhase 3May 1, 2015

Details

Founded: Fort Collins, CO, US Jun 1, 2006
Last known activity: May 10, 2024